Table 1. Numbers, age group, and case–control status of participants by site for whom peripheral blood mononuclear cells (PBMC) RNA-seq data were available at months 0 and/or 3.
Month 0 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cases (n = 14) | Controls (n = 43) | Not included in the case–control (n = 70) | ||||||||||
Bagomoyo | Manhiça | Bagomoyo | Manhiça | Bagomoyo | Manhiça | |||||||
Infants | Children | Infants | Children | Infants | Children | Infants | Children | Infants | Children | Infants | Children | |
RTS,S/AS01 (n = 88) | 0 | 9 | 0 | 0 | 0 | 29 | 0 | 0 | 0 | 41 | 0 | 9 |
Comparator (n = 39) | 0 | 5 | 0 | 0 | 0 | 12 | 0 | 2 | 0 | 19 | 0 | 1 |
Month 3 | ||||||||||||
Cases (n = 54) | Controls (n = 142) | Not included in the case–control (n = 161) | ||||||||||
Bagomoyo | Manhiça | Bagomoyo | Manhiça | Bagomoyo | Manhiça | |||||||
Infants | Children | Infants | Children | Infants | Children | Infants | Children | Infants | Children | Infants | Children | |
RTS,S/AS01 (n = 222) | 0 | 19 | 12 | 0 | 0 | 51 | 41 | 0 | 0 | 56 | 28 | 15 |
Comparator (n = 135) | 0 | 16 | 6 | 1 | 0 | 30 | 16 | 4 | 0 | 29 | 29 | 4 |